Overview

GLP-1 CellBeads® for the Treatment of Stroke Patients With Space-occupying Intracerebral Hemorrhage

Status:
Terminated
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the safety of GLP-1 CellBeads® in patients with space-occupying intracerebral hemorrhage.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
CellMed AG, a subsidiary of BTG plc.
Treatments:
Glucagon
Glucagon-Like Peptide 1